CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-09 | Furlow Brenda S. SVP - General Counsel | Sale | −918 | $274.80 | $252K | 9,485 |
| 2020-07-09 | Furlow Brenda S. SVP - General Counsel | Sale | −400 | $276.03 | $110K | 9,085 |
| 2020-07-09 | Furlow Brenda S. SVP - General Counsel | Sale | −1,954 | $277.28 | $542K | 7,131 |
| 2020-07-09 | Furlow Brenda S. SVP - General Counsel | Sale | −2,746 | $278.06 | $764K | 4,385 |
| 2020-07-09 | Furlow Brenda S. SVP - General Counsel | Sale | −74 | $278.84 | $21K | 4,311 |
| 2020-07-09 | Furlow Brenda S. SVP - General Counsel | Option exercise · Stock Option (Right to Buy) | −9,079 | 921 | ||
| 2020-07-07 | Hippel James Chief Financial Officer | Option exercise | +2,577 | $108.49 | $280K | 11,884 |
| 2020-07-07 | Hippel James Chief Financial Officer | Sale | −414 | $270.56 | $112K | 11,470 |
| 2020-07-07 | Hippel James Chief Financial Officer | Sale | −1,663 | $271.40 | $451K | 9,807 |
| 2020-07-07 | Hippel James Chief Financial Officer | Sale | −500 | $272.26 | $136K | 9,307 |
| 2020-07-07 | Hippel James Chief Financial Officer | Option exercise · Stock Options (Right to Buy) | −2,577 | 15,909 | ||
| 2020-07-06 | Hippel James Chief Financial Officer | Option exercise | +21,502 | $108.49 | $2.3M | 30,809 |
| 2020-07-06 | Hippel James Chief Financial Officer | Sale | −9,571 | $270.45 | $2.6M | 21,238 |
| 2020-07-06 | Hippel James Chief Financial Officer | Sale | −3,781 | $271.53 | $1.0M | 17,457 |
| 2020-07-06 | Hippel James Chief Financial Officer | Sale | −4,947 | $272.34 | $1.3M | 12,510 |
| 2020-07-06 | Hippel James Chief Financial Officer | Sale | −1,934 | $273.71 | $529K | 10,576 |
| 2020-07-06 | Hippel James Chief Financial Officer | Sale | −1,269 | $274.52 | $348K | 9,307 |
| 2020-07-06 | Hippel James Chief Financial Officer | Option exercise · Stock Options (Right to Buy) | −21,502 | 18,486 | ||
| 2020-05-29 | WIENS HAROLD J Director | Option exercise | +3,985 | $101.19 | $403K | 8,828 |
| 2020-05-29 | WIENS HAROLD J Director | Sale | −3,985 | $260.00 | $1.0M | 4,843 |
Page 43 of 53 · 1,043 trades